TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair